QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2023.
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission File Number 1-12273
ROPER TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Delaware
51-0263969
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
6901 Professional Parkway, Suite 200
Sarasota,
Florida
34240
(Address of principal executive offices)
(Zip Code)
(941) 556-2601
(Registrant’s telephone number, including area code)
(Former name, former address and former fiscal year, if changed since last report)
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of Each Class
Trading Symbol(s)
Name of Each Exchange On Which Registered
Common Stock, $0.01 Par Value
ROP
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒Yes☐ No
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
☒Yes☐ No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
☒
Large accelerated filer
☐
Accelerated filer
☐
Non-accelerated filer
☐
Smaller reporting company
☐
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No
The number of shares outstanding of the registrant’s common stock as of April 28, 2023 was 106,592,234.
1
ROPER TECHNOLOGIES, INC.
REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023
Condensed Consolidated Statements of Earnings (unaudited)
(in millions, except per share data)
Three months ended March 31,
2023
2022
Net revenues
$
1,469.7
$
1,279.8
Cost of sales
451.1
382.6
Gross profit
1,018.6
897.2
Selling, general and administrative expenses
617.6
541.3
Income from operations
401.0
355.9
Interest expense, net
37.4
52.6
Equity investment activity, net
(1.2)
—
Other expense, net
(2.3)
(2.1)
Earnings before income taxes
360.1
301.2
Income taxes
75.8
64.8
Net earnings from continuing operations
284.3
236.4
Earnings (loss) from discontinued operations, net of tax
(1.2)
66.8
Gain on disposition of discontinued operations, net of tax
—
1,717.3
Net earnings (loss) from discontinued operations
(1.2)
1,784.1
Net earnings
$
283.1
$
2,020.5
Net earnings per share from continuing operations:
Basic
$
2.67
$
2.24
Diluted
$
2.66
$
2.22
Net earnings (loss) per share from discontinued operations:
Basic
$
(0.01)
$
16.89
Diluted
$
(0.01)
$
16.72
Net earnings per share:
Basic
$
2.66
$
19.13
Diluted
$
2.65
$
18.94
Weighted average common shares outstanding:
Basic
106.3
105.6
Diluted
107.0
106.7
See accompanying notes to Condensed Consolidated Financial Statements.
3
Roper Technologies, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (unaudited)
(in millions)
Three months ended March 31,
2023
2022
Net earnings
$
283.1
$
2,020.5
Other comprehensive income (loss), net of tax:
Foreign currency translation adjustments
24.1
(22.9)
Total other comprehensive income (loss), net of tax
24.1
(22.9)
Comprehensive income
$
307.2
$
1,997.6
See accompanying notes to Condensed Consolidated Financial Statements.
4
Roper Technologies, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (unaudited)
(in millions)
March 31, 2023
December 31, 2022
ASSETS:
Cash and cash equivalents
$
1,181.6
$
792.8
Accounts receivable, net
629.1
724.5
Inventories, net
115.0
111.3
Income taxes receivable
25.5
61.0
Unbilled receivables
100.9
91.5
Other current assets
180.1
151.3
Total current assets
2,232.2
1,932.4
Property, plant and equipment, net
86.3
85.3
Goodwill
15,962.8
15,946.1
Other intangible assets, net
7,871.7
8,030.7
Deferred taxes
59.3
55.9
Equity investment
535.0
535.0
Other assets
387.5
395.4
Total assets
$
27,134.8
$
26,980.8
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable
$
134.0
$
122.6
Accrued compensation
154.2
228.8
Deferred revenue
1,303.8
1,370.7
Other accrued liabilities
413.4
454.6
Income taxes payable
70.5
16.6
Current portion of long-term debt, net
699.5
699.2
Total current liabilities
2,775.4
2,892.5
Long-term debt, net of current portion
5,964.4
5,962.5
Deferred taxes
1,652.9
1,676.8
Other liabilities
409.4
411.2
Total liabilities
10,802.1
10,943.0
Commitments and contingencies (Note9)
Common stock
1.1
1.1
Additional paid-in capital
2,570.4
2,510.2
Retained earnings
13,941.2
13,730.7
Accumulated other comprehensive loss
(162.9)
(187.0)
Treasury stock
(17.1)
(17.2)
Total stockholders' equity
16,332.7
16,037.8
Total liabilities and stockholders' equity
$
27,134.8
$
26,980.8
See accompanying notes to Condensed Consolidated Financial Statements.
5
Roper Technologies, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited)
(in millions)
Three months ended March 31,
2023
2022
Cash flows from operating activities:
Net earnings from continuing operations
$
284.3
$
236.4
Adjustments to reconcile net earnings from continuing operations to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment
8.6
9.6
Amortization of intangible assets
175.1
145.7
Amortization of deferred financing costs
2.6
3.1
Non-cash stock compensation
29.6
33.0
Income tax provision, excluding tax associated with gain on sale of assets
75.8
64.8
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable
98.0
85.6
Unbilled receivables
(8.7)
(10.4)
Inventories
(3.8)
(13.0)
Accounts payable
11.2
10.1
Other accrued liabilities
(103.7)
(106.6)
Deferred revenue
(61.4)
28.4
Cash income taxes paid
(16.0)
(22.3)
Other, net
(26.7)
(23.1)
Cash provided by operating activities from continuing operations
464.9
441.3
Cash provided by (used in) operating activities from discontinued operations
(1.2)
34.0
Cash provided by operating activities
463.7
475.3
Cash flows from (used in) investing activities:
Acquisitions of businesses, net of cash acquired
(1.1)
(53.2)
Capital expenditures
(9.8)
(5.4)
Capitalized software expenditures
(9.9)
(7.5)
Other, net
(2.8)
—
Cash used in investing activities from continuing operations
(23.6)
(66.1)
Proceeds from (used in) disposition of discontinued operations
(3.2)
3,006.2
Cash used in investing activities from discontinued operations
—
(1.9)
Cash provided by (used in) investing activities
(26.8)
2,938.2
Cash flows from (used in) financing activities:
Borrowings (payments) under revolving line of credit, net
—
(470.0)
Cash dividends to stockholders
(72.3)
(65.3)
Proceeds from stock-based compensation, net
15.1
21.0
Treasury stock sales
4.7
5.5
Cash flows used in financing activities from continuing operations
(52.5)
(508.8)
Cash flows used in financing activities from discontinued operations
—
(11.4)
Cash flows used in financing activities
(52.5)
(520.2)
(Continued)
6
Roper Technologies, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited) - Continued
(in millions)
Three months ended March 31,
2023
2022
Effect of foreign currency exchange rate changes on cash
4.4
(7.3)
Net increase in cash and cash equivalents
388.8
2,886.0
Cash and cash equivalents, beginning of period
792.8
351.5
Cash and cash equivalents, end of period
$
1,181.6
$
3,237.5
See accompanying notes to Condensed Consolidated Financial Statements.
7
Roper Technologies, Inc. and Subsidiaries
Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited)
(in millions)
Common stock
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Treasury stock
Total stockholders’ equity
Balances at December 31, 2022
$
1.1
$
2,510.2
$
13,730.7
$
(187.0)
$
(17.2)
$
16,037.8
Net earnings
—
—
283.1
—
—
283.1
Stock option exercises
—
33.7
—
—
—
33.7
Treasury stock sold
—
4.6
—
—
0.1
4.7
Currency translation adjustments
—
—
—
24.1
—
24.1
Stock-based compensation
—
31.4
—
—
—
31.4
Restricted stock activity
—
(9.5)
—
—
—
(9.5)
Dividends declared ($0.6825 per share)
—
—
(72.6)
—
—
(72.6)
Balances at March 31, 2023
$
1.1
$
2,570.4
$
13,941.2
$
(162.9)
$
(17.1)
$
16,332.7
Balances at December 31, 2021
$
1.1
$
2,307.8
$
9,455.6
$
(183.1)
$
(17.6)
$
11,563.8
Net earnings
—
—
2,020.5
—
—
2,020.5
Stock option exercises
—
38.7
—
—
—
38.7
Cash settlement of share-based awards in connection with disposition of discontinued operations
—
(11.1)
—
—
—
(11.1)
Treasury stock sold
—
5.4
—
—
0.1
5.5
Currency translation adjustments
—
—
—
(22.9)
—
(22.9)
Stock-based compensation
—
40.8
—
—
—
40.8
Restricted stock activity
—
(17.7)
—
—
—
(17.7)
Dividends declared ($0.62 per share)
—
—
(65.7)
—
—
(65.7)
Balances at March 31, 2022
$
1.1
$
2,363.9
$
11,410.4
$
(206.0)
$
(17.5)
$
13,551.9
See accompanying notes to Condensed Consolidated Financial Statements.
8
Roper Technologies, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements (unaudited)
All currency and share amounts are in millions, except per share data
1. Basis of Presentation
The accompanying Condensed Consolidated Financial Statements for the three months ended March 31, 2023 and 2022 are unaudited. In the opinion of management, the accompanying unaudited Condensed Consolidated Financial Statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Technologies, Inc. and its subsidiaries (“Roper,” the “Company,” “we,” “our” or “us”) for all periods presented. The December 31, 2022 financial position data included herein was derived from the audited consolidated financial statements included in the Company’s 2022 Annual Report on Form 10-K (“Annual Report”) filed on February 27, 2023 with the Securities and Exchange Commission (“SEC”) but does not include all disclosures required by U.S. generally accepted accounting principles (“GAAP”).
Roper’s management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these Condensed Consolidated Financial Statements in conformity with GAAP. Actual results could differ from those estimates.
The results of operations for the three months ended March 31, 2023 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited Condensed Consolidated Financial Statements in conjunction with Roper’s audited consolidated financial statements and the notes thereto included in its Annual Report. Certain prior period amounts have been reclassified to conform to current period presentation.
Discontinued Operations
Roper has completed the divestitures of TransCore, Zetec, CIVCO Radiotherapy (“2021 Divestitures”), and the majority stake in its industrial businesses (“Indicor”). The financial results for these businesses are reported as discontinued operations for all periods presented. Unless otherwise noted, discussion within these notes to the Condensed Consolidated Financial Statements relates to continuing operations. Refer to Note 4 for additional information on discontinued operations.
2. Recent Accounting Pronouncements
The Financial Accounting Standards Board (“FASB”) establishes changes to accounting principles under GAAP in the form of accounting standards updates (“ASUs”) to the Accounting Standards Codification (“ASC”). The Company considers the applicability and impact of all ASUs. Any recent ASUs were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company’s results of operations, financial position or cash flows.
3. Weighted Average Shares Outstanding
Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options based upon the trading price of Roper’s common stock. The effects of potential common stock were determined using the treasury stock method.
9
Weighted average shares outstanding are shown below:
Three months ended March 31,
2023
2022
Basic shares outstanding
106.3
105.6
Effect of potential common stock:
Common stock awards
0.7
1.1
Diluted shares outstanding
107.0
106.7
For the three months ended March 31, 2023, there were 1.150 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 0.840 outstanding stock options that would have been antidilutive in the respective 2022 period.
4. Discontinued Operations
The Company concluded that the 2021 Divestitures and the sale of a majority 51% stake in Indicor each represented a strategic shift that had a major effect on the Company’s operations and financial results. Accordingly, the financial results related to these transactions are presented in the Condensed Consolidated Financial Statements as discontinued operations for all periods presented.
The following transactions closed in the first quarter of 2022:
•On March 17, 2022, Roper closed on the divestiture of our TransCore business to an affiliate of Singapore Technologies Engineering Ltd., for approximately $2,680.0 in cash. The sale resulted in a pretax gain of $2,073.7 and income tax expense of $550.5, which are reported within “Gain on disposition of discontinued operations, net of tax” in the Condensed Consolidated Statements of Earnings. TransCore was previously included in the historical Network Software & Systems reportable segment.
•On January 5, 2022, Roper closed on the divestiture of our Zetec business to Eddyfi NDT Inc. for approximately $350.0 in cash. The sale resulted in a pretax gain of $255.3 and income tax expense of $60.9, which are reported within “Gain on disposition of discontinued operations, net of tax” in the Condensed Consolidated Statements of Earnings. Zetec was previously included in the historical Process Technologies reportable segment.
10
The following table summarizes the major classes of revenue and expenses constituting net income from discontinued operations attributable to the TransCore and Zetec businesses:
Three Months Ended March 31,
2022
Net revenues
$
100.4
Cost of sales
71.2
Gross profit
29.2
Selling, general and administrative expenses (1)
19.9
Income from operations
9.3
Other income, net
0.1
Earnings before income taxes
9.4
Income taxes
(6.2)
Earnings from discontinued operations, net of tax
15.6
Gain on disposition of discontinued operations, net of tax (2)
1,717.3
Net earnings from discontinued operations
$
1,732.9
(1) Includes stock-based compensation expense of $0.9. Stock-based compensation for discontinued operations was previously reported as a component of unallocated corporate general and administrative expenses.
(2) Includes expense of $4.5 associated with accelerated vesting of share-based awards.
11
Indicor - On November 22, 2022, Roper completed the divestiture of a majority 51% stake in Indicor to Clayton, Dubilier & Rice, LLC (“CD&R”). In connection with the transaction, Roper retained an initial 49% minority equity interest in Indicor (described further in Note 8).
The following table summarizes the major classes of revenue and expenses constituting net income from discontinued operations attributable to Indicor:
Three Months Ended March 31,
2023
2022 (1)
Net revenues
$
—
$
246.8
Cost of sales
—
113.9
Gross profit
—
132.9
Selling, general and administrative expenses
1.2
67.7
Income from operations
(1.2)
65.2
Other income, net
—
0.2
Earnings (loss) before income taxes
(1.2)
65.4
Income taxes
—
14.2
Earnings (loss) from discontinued operations, net of tax
$
(1.2)
$
51.2
(1) Includes depreciation and amortization expense of $3.9 and stock-based compensation expense of $2.9. Stock-based compensation was previously reported as a component of unallocated corporate general and administrative expenses.
5. Stock Based Compensation
The Roper Technologies, Inc. 2021 Incentive Plan is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper’s employees, officers, directors and consultants.
The following table provides information regarding the Company’s stock-based compensation expense:
Three Months Ended March 31,
2023
2022
Stock-based compensation
$
30.2
$
33.0
Tax effect recognized in net earnings from continuing operations
5.2
7.0
Stock Options - In the three months ended March 31, 2023, 0.353 options were granted with a weighted average fair value of $128.89 per option. During the same period in 2022, 0.365 options were granted with a weighted average fair value of $115.83 per option. All options were issued with an exercise price equal to the closing price of Roper’s common stock on the date of grant, as required by the Company’s stock-based compensation plans.
Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option.
12
The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year periods using the Black-Scholes option-pricing model:
Three months ended March 31,
2023
2022
Risk-free interest rate (%)
3.73
2.05
Expected option life (years)
5.65
5.63
Expected volatility (%)
26.02
24.52
Expected dividend yield (%)
0.64
0.54
Cash received from option exercises for the three months ended March 31, 2023 and 2022 was $24.6 and $38.7, respectively.
Restricted Stock Grants - During both the three months ended March 31, 2023 and 2022, the Company granted 0.219 shares with a weighted average grant date fair value of $428.20 and $455.84 per restricted share, respectively. All grants were issued at grant date fair value.
During the three months ended March 31, 2023, 0.082 restricted shares vested with a weighted average grant date fair value of $376.74 per restricted share and a weighted average vest date fair value of $435.75 per restricted share.
Employee Stock Purchase Plan - Roper’s employee stock purchase plan (“ESPP”) allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper’s common stock at a 10% discount on the lower of the closing price of the stock on the first and last day of each quarterly offering period. Common stock sold to employees pursuant to the ESPP may be either treasury stock, stock purchased on the open market, or newly issued shares.
During the three months ended March 31, 2023 and 2022, participants in the ESPP purchased 0.012 and 0.013 shares of Roper’s common stock for total consideration of $4.7 and $5.5, respectively. All shares were purchased from Roper’s treasury shares.
6. Inventories
The components of inventory were as follows:
March 31, 2023
December 31, 2022
Raw materials and supplies
$
63.0
$
60.6
Work in process
26.9
24.9
Finished products
32.1
31.3
Inventory reserves
(7.0)
(5.5)
Inventories, net
$
115.0
$
111.3
7. Goodwill and Other Intangible Assets
The carrying value of goodwill by segment was as follows:
Application Software
Network Software
Technology Enabled Products
Total
Balances at December 31, 2022
$
11,417.5
$
3,598.3
$
930.3
$
15,946.1
Other
0.1
—
—
0.1
Currency translation adjustments
5.9
10.9
(0.2)
16.6
Balances at March 31, 2023
$
11,423.5
$
3,609.2
$
930.1
$
15,962.8
Other relates primarily to purchase accounting adjustments for acquisitions completed in 2022.
13
Other intangible assets were comprised of:
Cost
Accumulated amortization
Net book value
Assets subject to amortization:
Customer related intangibles
$
9,300.7
$
(2,437.7)
$
6,863.0
Unpatented technology
954.6
(506.9)
447.7
Software
149.0
(134.0)
15.0
Patents and other protective rights
10.3
(1.2)
9.1
Trade names
9.7
(3.1)
6.6
Assets not subject to amortization:
Trade names
689.3
—
689.3
Balances at December 31, 2022
$
11,113.6
$
(3,082.9)
$
8,030.7
Assets subject to amortization:
Customer related intangibles
$
9,310.5
$
(2,576.2)
$
6,734.3
Unpatented technology
959.3
(539.4)
419.9
Software
149.1
(136.8)
12.3
Patents and other protective rights
10.3
(1.2)
9.1
Trade names
9.7
(3.8)
5.9
Assets not subject to amortization:
Trade names
690.2
—
690.2
Balances at March 31, 2023
$
11,129.1
$
(3,257.4)
$
7,871.7
Amortization expense of other intangible assets was $170.4 and $143.3 during the three months ended March 31, 2023 and 2022, respectively.
An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2023. The Company will perform the annual analysis during the fourth quarter of 2023.
8. Fair Value
Financial assets and liabilities are valued using market prices on active markets (Level 1), less active markets (Level 2) and little or no market activity (Level 3). Level 1 instrument valuations are obtained from real-time quotes for transactions in active exchange markets involving identical assets. Level 2 instrument valuations are obtained from readily available pricing sources for comparable instruments, identical instruments in less active markets, or models using market observable inputs. Level 3 instrument valuations typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.
14
Debt -Roper’s debt included $6,700 of fixed-rate senior notes with the following fair values:
Fixed-rate senior notes
Fair Value
Principal Amount
Interest rate
Year of maturity
As of March 31, 2023
$700
3.650%
2023
$
695
$500
2.350%
2024
$
482
$300
3.850%
2025
$
295
$700
1.000%
2025
$
641
$700
3.800%
2026
$
679
$700
1.400%
2027
$
609
$800
4.200%
2028
$
788
$700
2.950%
2029
$
629
$600
2.000%
2030
$
497
$1,000
1.750%
2031
$
803
The fair values of the senior notes are based on the trading prices of each series of notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.
Indicor Investment - Following the sale of a majority stake in its industrial businesses to CD&R, Roper now holds a minority 48.6% equity interest in Indicor. We elected to apply the fair value option as we believe this is the most reasonable method to value the equity investment. The fair value of Roper’s equity investment in Indicor is updated on a quarterly basis and its impact is reported as "Equity investment activity, net." There was no change in fair value between December 31, 2022 and March 31, 2023.
The assessment of fair value for the equity investment requires significant judgments to be made by management. Although our assumptions are considered reasonable and are consistent, there is significant judgment applied. Changes in estimates or the application of alternative assumptions could produce significantly different results. The fair value of the investment reflects management’s estimate of assumptions that market participants would use in pricing the equity interest, which the Company has determined to be Level 3 in the FASB fair value hierarchy.
On April 26, 2023, Indicor announced its planned divestiture of its Compressor Controls business unit to Honeywell International Inc. for approximately $670. This transaction will be contemplated in our assessment of the fair value of our equity investment in the second quarter.
9. Contingencies
Roper, in the ordinary course of business, is party to various pending or threatened legal actions, including product liability, intellectual property, antitrust, data privacy and employment practices that, in general, are of a nature consistent with those over the past several years. After analyzing the Company’s contingent liabilities on a gross basis and, based upon past experience with resolution of such legal claims and the availability and limits of the primary, excess, and umbrella liability insurance coverages with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper’s consolidated financial position, results of operations or cash flows. However, no assurances can be given in this regard.
Roper’s subsidiary, Vertafore, Inc., had been named in three putative class actions, all of which are now dismissed: two in the U.S. District Court for the Southern District of Texas (Allen, et al. v. Vertafore, Inc., Case 4:20-cv-4139, filed December 4, 2020) and Masciotra, et al. v. Vertafore, Inc. (originally filed on December 8, 2020 as Case 1:20-cv-03603 in the U.S. District Court for the District of Colorado and subsequently transferred)), and one in the U.S. District Court for the Northern District of Texas (Mulvey, et al. v. Vertafore, Inc., Case 3:21-cv-00213-E, filed January 31, 2021). In July 2021, the court granted Vertafore’s motion to dismiss the Allen Case, with the dismissal affirmed by the U.S. Fifth Circuit Court of Appeals, effectively concluding the litigation. In July 2021, the plaintiff in the Masciotra case voluntarily dismissed his action without prejudice. In February 2023, the court granted Vertafore’s motion to dismiss the Mulvey case, and Plaintiff failed to appeal the dismissal effectively concluding the matter. Both the Allen and Mulvey cases purported to represent approximately 27.7 million individuals who held Texas driver’s licenses prior to February 2019. In November 2020, Vertafore announced that as a result of
15
human error, three data files were inadvertently stored in an unsecured external storage service that appears to have been accessed without authorization. The files, which included driver information for licenses issued before February 2019, contained Texas driver license numbers, as well as names, dates of birth, addresses and vehicle registration histories. The files did not contain any Social Security numbers or financial account information. These cases sought recovery under the Driver’s Privacy Protection Act, 18 U.S.C. § 2721. As set forth above, all of these matters have now been dismissed.
Roper’s subsidiary, Verathon, Inc. (“Verathon”), was a defendant in a patent infringement action pending in the United States District Court for the Western District of Washington (Berall v. Verathon, Inc., Case No. 2:2021mc00043). The plaintiff claimed that video laryngoscopes and certain accessories sold by Verathon and other manufacturers from approximately 2004 through 2016 infringed U.S. Patent 5,827,178 (the “178 Patent”). Verathon and the plaintiff agreed to settle the matter for $45.0 which was fully concluded and cash settled in the first quarter of 2023.
10. Business Segments
The following table presents selected financial information by reportable segment:
Three months ended March 31,
2023
2022
Change %
Net revenues:
Application Software
$
761.4
$
628.2
21.2
%
Network Software
354.5
338.5
4.7
%
Technology Enabled Products
353.8
313.1
13.0
%
Total
$
1,469.7
$
1,279.8
14.8
%
Gross profit:
Application Software
$
520.5
$
435.4
19.5
%
Network Software
299.4
284.9
5.1
%
Technology Enabled Products
198.7
176.9
12.3
%
Total
$
1,018.6
$
897.2
13.5
%
Operating profit*:
Application Software
$
193.2
$
172.3
12.1
%
Network Software
147.5
136.8
7.8
%
Technology Enabled Products
115.5
99.7
15.8
%
Total
$
456.2
$
408.8
11.6
%
Long-lived assets:
Application Software
$
153.3
$
135.8
12.9
%
Network Software
30.7
26.2
17.2
%
Technology Enabled Products
29.2
27.0
8.1
%
Total
$
213.2
$
189.0
12.8
%
*Segment operating profit is before unallocated corporate general and administrative and enterprise-wide stock-based compensation expenses. These expenses were $55.2 and $52.9 for the three months ended March 31, 2023 and 2022, respectively.
16
11. Revenues from Contracts
Disaggregated Revenue - We disaggregate our revenues by reportable segment into four categories: (i) recurring revenue comprised of Software-as-a-Service (“SaaS”) licenses and software maintenance; (ii) reoccurring revenue comprised of transactional and volume-based fees related to software licenses; (iii) non-recurring revenue comprised of term and perpetual software licenses, professional services associated with software products and hardware sold with our software licenses; and (iv) product revenue. See details in the table below.
Three months ended March 31, 2023
Three months ended March 31, 2022
Application Software
Network Software
Technology Enabled Products
Total
Application Software
Network Software
Technology Enabled Products
Total
Revenue Stream
Software related
Recurring
$
580.6
$
255.9
$
3.8
$
840.3
$
461.5
$
237.2
$
2.6
$
701.3
Reoccurring
35.4
64.2
—
99.6
31.7
60.5
—
92.2
Non-recurring
145.4
34.4
0.4
180.2
135.0
40.8
0.3
176.1
Total Software Revenues
761.4
354.5
4.2
1,120.1
628.2
338.5
2.9
969.6
Product Revenue
—
—
349.6
349.6
—
—
310.2
310.2
Total Revenue
$
761.4
$
354.5
$
353.8
$
1,469.7
$
628.2
$
338.5
$
313.1
$
1,279.8
Remaining performance obligations - Remaining performance obligations represent the transaction price of firm orders for which work has not been performed and excludes unexercised contract options. As of March 31, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was $4,203.0. We expect to recognize revenue of $2,872.5, or approximately 68% of our remaining performance obligations over the next 12 months (“Backlog”), with the remainder to be recognized thereafter.
Contract balances
Balance Sheet Account
March 31, 2023
December 31, 2022
Change
Unbilled receivables
$
100.9
$
91.5
$
9.4
Deferred revenue - current
(1,303.8)
(1,370.7)
66.9
Deferred revenue - non-current (1)
(121.4)
(111.5)
(9.9)
Net contract assets/(liabilities)
$
(1,324.3)
$
(1,390.7)
$
66.4
(1)The non-current portion of deferred revenue is included in “Other liabilities” in our Condensed Consolidated Balance Sheets.
The change in our net contract assets/(liabilities) from December 31, 2022 to March 31, 2023 was due primarily to the timing of payments and invoicing relating to SaaS and post contract support (“PCS”) contracts, driven largely by the renewal cycle of our Frontline business which primarily occurs in the third quarter.
The Company records deferred revenue when cash payments are received or due in advance of the Company’s performance relating primarily to SaaS and PCS renewals. Revenue recognized from the deferred revenue balance on December 31, 2022 and 2021 was $589.9 and $489.3 for the three months ended March 31, 2023 and 2022, respectively. In order to determine revenues recognized in the period, we allocate revenue to the individual deferred revenue balance outstanding at the beginning of the year until the revenue exceeds that balance.
The current and non-current portions of deferred commissions are included in “Other current assets” and “Other assets,” respectively, in our Condensed Consolidated Balance Sheets. At March 31, 2023 and December 31, 2022, we had $64.5 and $64.8 of total deferred commissions, respectively.
17
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
You should read the following discussion in conjunction with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on form 10-K for the year ended December 31, 2022 (“Annual Report”) as filed on February 27, 2023 with the U.S. Securities and Exchange Commission (“SEC”) and the Notes to Condensed Consolidated Financial Statements included elsewhere in this report.
Information About Forward-Looking Statements
This report includes “forward-looking statements” within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the SEC or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are “forward-looking statements.” Forward-looking statements may be indicated by words or phrases such as “anticipate,” “estimate,” “plans,” “expects,” “projects,” “should,” “will,” “believes” or “intends” and similar words and phrases. These statements reflect management’s current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement. Such risks and uncertainties include any ongoing impacts of the COVID-19 pandemic on our business, operations, financial results and liquidity, which will depend on numerous evolving factors that we cannot accurately predict or assess, including: any negative impact on global and regional markets, economies and economic activity, our customers, suppliers, and business partners, and how quickly and whether economies and demand for our products and services recover.
Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our operating plans, our expectations regarding our ability to generate cash and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, demand for our products, the cost, timing and success of product upgrades and new product introductions, raw material costs, expected pricing levels, expected outcomes of pending litigation, competitive conditions and general economic conditions. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include but are not limited to:
•general economic conditions;
•difficulty making acquisitions and successfully integrating acquired businesses;
•any unforeseen liabilities associated with future acquisitions;
•failure to effectively mitigate cybersecurity threats, including any litigation arising therefrom;
•failure to comply with new data privacy laws and regulations, including any litigation arising therefrom;
•risks and costs associated with our international sales and operations;
•rising interest rates;
•limitations on our business imposed by our indebtedness;
•product liability, litigation, and insurance risks;
•future competition;
•the cyclical nature of some of our markets;
•reduction of business with large customers;
•risks associated with government contracts;
•changes in the supply of, or price for, labor, energy, raw materials, parts and components, including as a result of impacts from the current inflationary environment, supply chain constraints or additional or ongoing impacts of the COVID-19 pandemic;
•potential write-offs of our goodwill and other intangible assets;
•our ability to successfully develop new products;
•failure to protect our intellectual property;
•unfavorable changes in foreign exchange rates;
•difficulties associated with exports/imports and risks of changes to tariff rates;
•increased warranty exposure;
•environmental compliance costs and liabilities;
•the effect of, or change in, government regulations (including tax);
•economic disruption caused by armed conflicts (such as the war in Ukraine), terrorist attacks, health crises (such as the COVID-19 pandemic) or other unforeseen geopolitical events; and
18
•the factors discussed in other reports we file with the SEC from time to time.
You should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.
Overview
Roper is a diversified technology company. Roper has a proven, long-term, successful track record of compounding cash flow and shareholder value. We operate market leading businesses that design and develop vertical software and technology enabled products for a variety of defensible niche markets.
We pursue consistent and sustainable growth in revenue, earnings and cash flow by enabling continuous improvement in the operating performance of our businesses and by acquiring other businesses that offer high value-added software, services, technology-enabled products and solutions that we believe are capable of achieving growth and maintaining high margins.
Discontinued Operations
Roper has completed the divestitures of TransCore, Zetec, CIVCO Radiotherapy (“2021 Divestitures”), and the majority stake in its industrial businesses (“Indicor” or “Indicor Transaction”). The financial results for these businesses are reported as discontinued operations for all periods presented. Unless otherwise noted, discussion within these notes to the Condensed Consolidated Financial Statements relates to continuing operations. Refer to Note 4 for additional information on discontinued operations.
Critical Accounting Policies
There were no material changes during the three months ended March 31, 2023 to the items that we disclosed as our critical accounting policies and estimates in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report.
Recently Issued Accounting Standards
Information regarding new accounting pronouncements is included in Note 2 of the Notes to Condensed Consolidated Financial Statements.
19
Results of Continuing Operations
All currency amounts are in millions, percentages are of net revenues
Percentages may not sum due to rounding.
The following table sets forth selected information for the periods indicated.
Three months ended March 31,
2023
2022
Net revenues:
Application Software
$
761.4
$
628.2
Network Software
354.5
338.5
Technology Enabled Products
353.8
313.1
Total
$
1,469.7
$
1,279.8
Gross margin:
Application Software
68.4
%
69.3
%
Network Software
84.5
84.2
Technology Enabled Products
56.2
56.5
Total
69.3
70.1
Selling, general and administrative expenses:
Application Software
43.0
%
41.9
%
Network Software
42.8
43.8
Technology Enabled Products
23.5
24.7
Total
38.3
38.2
Segment operating margin:
Application Software
25.4
%
27.4
%
Network Software
41.6
40.4
Technology Enabled Products
32.6
31.8
Total
31.0
31.9
Corporate administrative expenses
(3.8)
(4.1)
Income from operations
27.3
27.8
Interest expense, net
(2.5)
(4.1)
Equity investment activity, net
(0.1)
—
Other expense, net
(0.2)
(0.2)
Earnings before income taxes
24.5
23.5
Income taxes
(5.2)
(5.1)
Net earnings from continuing operations
19.3
%
18.5
%
20
Three months ended March 31, 2023 compared to three months ended March 31, 2022
Net revenues for the three months ended March 31, 2023 increased by 14.8% as compared to the three months ended March 31, 2022. The components of revenue growth for the three months ended March 31, 2023 were as follows:
Application Software
Network Software
Technology Enabled Products
Roper
Total Revenue Growth
21.2
%
4.7
%
13.0
%
14.8
%
Less Impact of:
Acquisitions/Divestitures
16.2
—
—
8.0
Foreign Exchange
(0.9)
(1.3)
(0.7)
(1.1)
Organic Revenue Growth
5.9
%
6.0
%
13.7
%
7.9
%
In our Application Software segment, revenues were $761.4 in the three months ended March 31, 2023 as compared to $628.2 in the three months ended March 31, 2022. The growth of 5.9% in organic revenues was broad-based across the segment led by our businesses serving government contracting, higher education, legal and property and casualty insurance markets. Gross margin decreased to 68.4% in the three months ended March 31, 2023 as compared to 69.3% in the three months ended March 31, 2022 due primarily to headcount to support growth, and a higher mix of SaaS and professional service revenue across a number of businesses. SG&A expenses increased as a percentage of revenue to 43.0% in the three months ended March 31, 2023 as compared to 41.9% in the three months ended March 31, 2022 due primarily to higher amortization of acquired intangibles from the Frontline acquisition. The resulting operating margin was 25.4% in the three months ended March 31, 2023 as compared to 27.4% in the three months ended March 31, 2022.
In our Network Software segment, revenues were $354.5 in the three months ended March 31, 2023 as compared to $338.5 in the three months ended March 31, 2022. The growth of 6.0% in organic revenues was led by our network software businesses serving the freight match, life insurance and alternate site healthcare markets. Gross margin increased to 84.5% in the three months ended March 31, 2023 as compared to 84.2% in the three months ended March 31, 2022 due to operating leverage on higher organic revenues. SG&A expenses decreased as a percentage of revenues at 42.8% in the three months ended March 31, 2023 as compared to 43.8% in the three months ended March 31, 2022 due to operating leverage on higher organic revenues combined with revenue mix. As a result, operating margin was 41.6% in the three months ended March 31, 2023 as compared to 40.4% in the three months ended March 31, 2022.
In our Technology Enabled Products segment, revenues were $353.8 in the three months ended March 31, 2023 as compared to $313.1 in the three months ended March 31, 2022. The growth of 13.7% in organic revenues was led by our water meter technology and medical products businesses. Gross margin decreased to 56.2% in the three months ended March 31, 2023 as compared to 56.5% in the three months ended March 31, 2022 due primarily to revenue mix partially offset by operating leverage on higher organic sales. SG&A expenses as a percentage of revenues decreased to 23.5% in the three months ended March 31, 2023 as compared to 24.7% in the three months ended March 31, 2022 due primarily to operating leverage on higher organic revenues. The resulting operating margin was 32.6% in the three months ended March 31, 2023 as compared to 31.8% in the three months ended March 31, 2022.
Corporate expenses increased to $55.2, or 3.8% of revenues, in the three months ended March 31, 2023 as compared to $52.9, or 4.1% of revenues, in the three months ended March 31, 2022. The dollar increase was due primarily to higher professional services expense partially offset by lower compensation expense.
Net interest expense decreased to $37.4 for the three months ended March 31, 2023 as compared to $52.6 for the three months ended March 31, 2022 due to higher interest income earned on our cash and cash equivalents and lower weighted average debt balances.
Equity investment activity, net was $1.2 for the three months ended March 31, 2023 due to non-cash stock compensation runoff expenses for Indicor employees which will not recur.
Other expense, net, of $2.3 for the three months ended March 31, 2023 was composed primarily of foreign exchange losses at our non-U.S. based subsidiaries. Other expense, net, of $2.1 for the three months ended March 31, 2022 was composed primarily of a one-time charge associated with a transaction to transfer the remainder of our exposure related to asbestos claims within the Indicor parameter to a third party, partially offset by foreign exchange gains at our non-U.S. based subsidiaries.
21
Income taxes as a percent of pretax earnings were 21.0% for the three months ended March 31, 2023 as compared to 21.5% for the three months ended March 31, 2022. The rate was primarily impacted by an increase in research and development (R&D) tax credit utilization and a benefit from foreign-derived intangible income.
Backlog is equal to our remaining performance obligations expected to be recognized within the next 12 months as discussed in Note 11 of the Notes to Condensed Consolidated Financial Statements. Backlog increased 17% to $2,872.5 at March 31, 2023 as compared to $2,455.6 at March 31, 2022. Organic growth in backlog was 13% and acquisitions contributed 5% which was partially offset by foreign exchange impact of 1%.
Backlog as of
March 31,
2023
2022
Application Software
$
1,706.3
$
1,567.5
Network Software
523.1
450.4
Technology Enabled Products
643.1
437.7
Total
$
2,872.5
$
2,455.6
Financial Condition, Liquidity and Capital Resources
All currency amounts are in millions
Selected cash flows for the three months ended March 31, 2023 and 2022 were as follows:
Three months ended March 31,
Cash provided by (used in):
2023
2022
Continuing operations:
Cash provided by operating activities
$
464.9
$
441.3
Cash used in investing activities
(23.6)
(66.1)
Cash used in financing activities
(52.5)
(508.8)
Cash provided by (used in) discontinued operations
(4.4)
3,026.9
Operating activities - Net cash provided by operating activities from continuing operations increased by 5% to $464.9 in the three months ended March 31, 2023 as compared to $441.3 in the three months ended March 31, 2022, due to higher net income from continuing operations net of non-cash expenses. These cash inflows were partially offset by less cash provided by working capital primarily due to the timing of SaaS renewals primarily associated with Frontline and cash payment of $45.0 million related to the settlement of the Berall v. Verathon patent litigation matter.
Investing activities - Cash used in investing activities from continuing operations during the three months ended March 31, 2023 is primarily due to capitalized software expenditures and capital expenditures. Cash used in investing activities from continuing operations during the three months ended March 31, 2022 was due primarily to business acquisitions.
Financing activities - Cash used in financing activities from continuing operations for the three months ended March 31, 2023 was primarily due to dividend payments. Cash used in financing activities for the three months ended March 31, 2022 was primarily due to repayments on our unsecured credit facility and dividend payments.
Discontinued operations - Cash provided by discontinued operations during the three months ended March 31, 2022 was primarily due to proceeds received from the sale of TransCore and Zetec.
22
Total debt consisted of the following:
As of March 31, 2023
Fixed-rate senior notes
$
6,700.0
Unsecured credit facility
—
Deferred finance costs
(36.4)
Other
0.3
Total debt, net of deferred finance costs
6,663.9
Less current portion
699.5
Long-term debt, net of deferred finance costs
$
5,964.4
The interest rate on borrowings under the $3,500.0 unsecured credit facility is calculated based upon various recognized indices plus a margin as defined in the credit facility. At March 31, 2023, we had no outstanding borrowings under our unsecured credit facility and $19.1 of outstanding letters of credit.
Cash at our foreign subsidiaries at March 31, 2023 increased to $277.9 as compared to $234.0 at December 31, 2022 due primarily to the cash generated at our foreign subsidiaries during the three months ended March 31, 2023. We intend to repatriate substantially all historical and future earnings.
We expect existing cash balances, together with cash generated by our operations and amounts available under our credit facility, will be sufficient to fund our operating requirements for the foreseeable future.
We were in compliance with all debt covenants related to our unsecured credit facility throughout the three months ended March 31, 2023.
Net working capital (total current assets, excluding cash less total current liabilities, excluding debt) was negative $1,025.3 at March 31, 2023 as compared to negative $1,053.7 at December 31, 2022 primarily driven by payments for accrued compensation, reduction in deferred revenue due to the timing of Frontline renewals, and the cash payment related to the settlement of the Berall v. Verathon patent litigation matter which were offset by collections on accounts receivable and an increase in income taxes payable. Total debt, net of deferred finance costs was $6,663.9 at March 31, 2023 as compared to $6,661.7 at December 31, 2022. Our leverage on a continuing operations basis is shown in the following table:
March 31, 2023
December 31, 2022
Total debt, net of deferred finance costs
$
6,663.9
$
6,661.7
Cash
(1,181.6)
(792.8)
Net debt
5,482.3
5,868.9
Stockholders’ equity
16,332.7
16,037.8
Total net capital
$
21,815.0
$
21,906.7
Net debt / total net capital
25.1
%
26.8
%
Capital expenditures were $9.8 for the three months ended March 31, 2023 as compared to $5.4 for the three months ended March 31, 2022. Capitalized software expenditures were $9.9 for the three months ended March 31, 2023 as compared to $7.5 for the three months ended March 31, 2022. We expect the aggregate of capital expenditures and capitalized software expenditures for the balance of the year to be comparable to prior years as a percentage of revenues.
Off-Balance Sheet Arrangements
At March 31, 2023, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.
23
Outlook
Current geopolitical and economic uncertainties, including the current inflationary environment, supply chain disruptions and labor shortages, could adversely affect our business prospects. An armed conflict (such as the ongoing war in Ukraine), significant terrorist attack, other global conflict, or new or ongoing public health crisis (such as the COVID-19 pandemic) could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these potential factor’s future effects on current economic conditions or any of our businesses. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also would similarly disrupt the economy and have an adverse impact on our businesses.
We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit agreements, future cash flows from operations, future divestitures, the proceeds from the issuance of new debt or equity securities or any combination of these methods, the terms and availability of which will be subject to market and economic conditions generally.
We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt in accordance with the repayment schedule. However, the rate at which we can reduce our debt (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions, the financial performance of our existing companies and the impact of the aforementioned geopolitical and economic uncertainties and the financial markets generally. None of these factors can be predicted with certainty.
24
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
See “Item 7A. Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report. There were no material changes during the three months ended March 31, 2023.
ITEM 4. CONTROLS AND PROCEDURES
As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q (“Evaluation Date”). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.
Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
There were no changes to our internal controls during the period covered by this Quarterly Report on Form 10-Q that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.
25
PART II. OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS
Information pertaining to legal proceedings can be found in Note 9 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this Quarterly Report on Form 10-Q and is incorporated by reference herein.
ITEM 1A. RISK FACTORS
Information regarding risk factors can be found in “Management’s Discussion and Analysis of Financial Condition and Results of Operations - Information About Forward-Looking Statements,” in Part 1 - Item 2 of this Form 10-Q and in Part 1 - Item 1A of our 2022 Annual Report on Form 10-K. There have been no material changes during the three months ended March 31, 2023 to our risk factors previously disclosed in the 2022 Annual Report on Form 10-K.
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).
27
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Roper Technologies, Inc.
/S/ L. Neil Hunn
President and Chief Executive Officer
May 3, 2023
L. Neil Hunn
(Principal Executive Officer)
/S/ Jason P. Conley
Executive Vice President and Chief Financial Officer
